CANCER TYPE | VACCINE | MANUFACTURER | TRADE PRICE | RETAIL PRICE | SCHEDULE | WHO SHOULD GET VACCINATED | REFERENCES |
Cervical Cancer | CERVARIX | GSK | Rs: 3995 | Rs: 4700 | 0,1,6 Mo | 9-45 yrs old females | Pakistan Drug Manual 2019 |
Liver Cancer (Hepatitis B) | ENGERIX-B 10 mcg | GSK | Rs: 190 | Rs: 223 | 0,1,2 Mo | <10 yrs | Pakistan Drug Manual 2019 |
ENGERIX-B 20mcg | GSK | Rs: 314 | Rs: 369 | 0,1,6 Mo | 10 yrs and above | Pakistan Drug Manual 2019 |
Immune System Deficiency: Women with deficient (lower) immune system having high risk of developing cervical cancer. Lower immune system could be due to prolong use of steroid, in organ transplanted persons, in persons received treatment of some other cancer in near past or due to HIV (human immunodeficiency virus). Whatever the reason of immune system deficiency, an immunodeficient individual would not be able to fight with HPV infection (which is very common) and may have Cervical cancer.
Sexually Transmittable Diseases: women having sexually transmittable diseases (STDs) or having a sexual partner suffering with STD having high risk of developing cervical cancer.
Smoking: smoker women are at double risk of developing cervical cancer.
Lower Socioeconomical status: Cervical cancer is more seen in women belongs to poor socioeconomical status. One reason behind this is probably this group of women has less access to health care providers and screening systems. Another reason is early start of sexual activity and multiple sexual partners.
Oral Contraceptive Use: oral contraceptive ( birth control pills) may be associated with cervical cancer development suggested by some research studies, but actual phenomenon is not well understood. More studies are required.
Diet: diet deficient in fruits and vegetables is not balanced; it leads to deficient immune system and increased risk of cervical cancer.
WhatsApp us